Radiosensitivity Is an Acquired Vulnerability of PARPi-resistant BRCA1-deficient Tumors

Cancer Research - United States
doi 10.1158/0008-5472.can-18-2077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors

Molecular Cell
Cell BiologyMolecular Biology
2018English

Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors

Cancer Research
Cancer ResearchOncology
2012English

Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol

Cancer Prevention Research
MedicineCancer ResearchOncology
2012English

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors

PLoS ONE
Multidisciplinary
2012English

HSP90/AXL/eIF4E-regulated Unfolded Protein Response as an Acquired Vulnerability in Drug-Resistant KRAS-mutant Lung Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2019English

P16INK4a Suppresses BRCA1-deficient Mammary Tumorigenesis

Oncotarget
Oncology
2016English

FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

Glutathione Metabolism: An Achilles’ Heel of ARID1A-Deficient Tumors

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Correlation of Radiosensitivity With Adverse Pathology in Prostate Tumors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy